Impact of vitamin D on amyloid precursor protein processing and amyloid-β peptide degradation in alzheimer's disease

Neurodegenerative Diseases

Volumn 13, Issue 2-3, 2014, Pages 75-81

  Grimm, Marcus O W ^a,b   Lehmann, Johannes ^a   Mett, Janine ^a   Zimmer, Valerie C ^a   Grösgen, Sven ^a   Stahlmann, Christoph P ^a   Hundsdörfer, Benjamin ^a   Haupenthal, Viola J ^a   Rothhaar, Tatjana L ^a   Herr, Christian ^a   Bals, Robert ^a   Grimm, Heike S ^a   Hartmann, Tobias ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Saarland University ^*  (Germany)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Amyloid peptide degradation

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; BETA SECRETASE 1; COLECALCIFEROL; MEMBRANE METALLOENDOPEPTIDASE; 25 HYDROXYVITAMIN D; CALCIFEDIOL; CATHEPSIN B; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN CONVERTING ENZYME 2; GELATINASE A; GELATINASE B; INSULINASE; PLASMINOGEN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; VITAMIN D DEFICIENCY; CONFERENCE PAPER; NERVE CELL; PROTEIN EXPRESSION; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BLOTTING, WESTERN; CHOLECALCIFEROL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VITAMIN D DEFICIENCY;

EID: 84896692281     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000355462     Document Type: Article

References (20)

1. Selkoe DJ: Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81: 741-766.
2. Glenner GG, Wong CW: Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120: 885-890.
3. Nalivaeva NN, Fisk LR, Belyaev ND, Turner AJ: Amyloid-degrading enzymes as therapeu-tic targets in Alzheimer's disease. Curr Alzheimer Res 2008; 5: 212-224.
4. Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW: De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase. J Biol Chem 2003; 278: 38084-38093.
5. Cui X, Pelekanos M, Liu PY, Burne TH, Mc-Grath JJ, Eyles DW: The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat midbrain. Neuroscience 2013; 236: 77-87.
6. Annweiler C, Souberbielle JC, Schott AM, de Decker L, Berrut G, Beauchet O: Vitamin D in the elderly: 5 points to remember. Geriatr Psychol Neuropsychiatr Vieil 2011; 9: 259-267.
7. Llewellyn DJ, Lang IA, Langa KM, Melzer D: Vitamin D and cognitive impairment in the elderly US population. J Gerontol A Biol Sci Med Sci 2011; 66: 59-65.
8. Annweiler C, Allali G, Allain P, Bridenbaugh S, Schott AM, Kressig RW, Beauchet O: Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 2009; 16: 1083-1089.
9. Annweiler C, Beauchet O: Vitamin D-mentia: randomized clinical trials should be the next step. Neuroepidemiology 2011; 37: 249-258.
10. McCann JC, Ames BN: Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J 2008; 22: 982-1001.
11. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, Qui WQ, Bergethon P, Rosenberg IH, Folstein MF, Patz S, Bhadelia RA, Tucker KL: 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010; 74: 18-26.
12. 3-enriched diet correlates with a decrease of amyloid plaques in the brain of AβPP transgenic mice. J Alzheimers Dis 2011; 25: 295-307.
13. Langub MC, Herman JP, Malluche HH, Koszewski NJ: Evidence of functional vitamin D receptors in rat hippocampus. Neuroscience 2001; 104: 49-56.
14. Howell S, Caswell AM, Kenny AJ, Turner AJ: Membrane peptidases on human osteoblastlike cells in culture: hydrolysis of calcitonin and hormonal regulation of endopeptidase-24.11. Biochem J 1993; 290: 159-164.
15. Grimm MO, Rothhaar TL, Grosgen S, Burg VK, Hundsdorfer B, Haupenthal VJ, Friess P, Kins S, Grimm HS, Hartmann T: Trans fatty acids enhance amyloidogenic processing of the Alzheimer amyloid precursor protein (APP). J Nutr Biochem 2012; 23: 1214-1223.
16. Grimm MO, Haupenthal VJ, Rothhaar TL, Zimmer VC, Grosgen S, Hundsdorfer B, Lehmann J, Grimm HS, Hartmann T: Effect of different phospholipids on alpha-secretase activity in the non-amyloidogenic pathway of Alzheimer's disease. Int J Mol Sci 2013; 14: 5879-5898.
17. Grimm MO, Grosgen S, Rothhaar TL, Burg VK, Hundsdorfer B, Haupenthal VJ, Friess P, Muller U, Fassbender K, Riemenschneider M, Grimm HS, Hartmann T: Intracellular APP domain regulates serine-palmitoyl-CoA transferase expression and is affected in Alzheimer's disease. Int J Alzheimer Dis 2011; 2011: 695413.
18. Grimm MO, Kuchenbecker J, Grosgen S, Burg VK, Hundsdorfer B, Rothhaar TL, Friess P, de Wilde MC, Broersen LM, Penke B, Peter M, Vigh L, Grimm HS, Hartmann T: Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms. J Biol Chem 2011; 286: 14028-14039.
19. Miners JS, Verbeek MM, Rikkert MO, Kehoe PG, Love S: Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid. J Neurosci Methods 2008; 167: 229-236.
20. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.